The data presented here indicate for the first time—using a unique visfatin-human monocyte co-culture model—that visfatin may indirectly influence breast tumor progression, invasion, and metastasis, through a THP-1 specific ERK-CXCL1 pathway. Here, CXCL1 is linked to breast neoplasm.